Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Levofloxacin may cause skin discoloration and hair loss as side effects.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Early recognition and treatment of tinea capitis are crucial to prevent severe scalp issues and prolonged therapy.

Mogamulizumab can cause hair loss and skin rashes.

ATP helps prevent skin damage from vandetanib by reducing stress.

The HPV vaccine may be linked to temporary hair loss in children, but the benefits outweigh the risks.

A man developed skin issues from cancer medication, which improved with specific treatments.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

The pandemic likely caused delays in skin cancer assessments, leading to fewer early diagnoses and thicker melanomas.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

A woman was allergic to quinine in her anti-hair loss lotion.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Two children grew extra hair from taking omeprazole, which went away after they stopped the medication.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Latanoprost 0.1% may effectively treat hair loss.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

Dermatologists should customize cosmetic treatments for dark-skinned patients to minimize risks and complications.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.